ZA201103421B - Improved dissolution stability of calcium carbonate tablets - Google Patents

Improved dissolution stability of calcium carbonate tablets

Info

Publication number
ZA201103421B
ZA201103421B ZA2011/03421A ZA201103421A ZA201103421B ZA 201103421 B ZA201103421 B ZA 201103421B ZA 2011/03421 A ZA2011/03421 A ZA 2011/03421A ZA 201103421 A ZA201103421 A ZA 201103421A ZA 201103421 B ZA201103421 B ZA 201103421B
Authority
ZA
South Africa
Prior art keywords
calcium carbonate
improved dissolution
dissolution stability
carbonate tablets
tablets
Prior art date
Application number
ZA2011/03421A
Other languages
English (en)
Inventor
Peder Mohr Olsen
Thomas Thisted
Poul Egon Bertelsen
Henrik Ravn Aage
Original Assignee
Takeda Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Nycomed As filed Critical Takeda Nycomed As
Publication of ZA201103421B publication Critical patent/ZA201103421B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA2011/03421A 2008-11-17 2011-05-10 Improved dissolution stability of calcium carbonate tablets ZA201103421B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08169264 2008-11-17
PCT/EP2009/008157 WO2010054845A1 (en) 2008-11-17 2009-11-17 Improved dissolution stability of calcium carbonate tablets

Publications (1)

Publication Number Publication Date
ZA201103421B true ZA201103421B (en) 2012-10-31

Family

ID=40456895

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2011/03421A ZA201103421B (en) 2008-11-17 2011-05-10 Improved dissolution stability of calcium carbonate tablets

Country Status (22)

Country Link
US (2) US9101565B2 (enExample)
EP (1) EP2358374B1 (enExample)
JP (1) JP5523467B2 (enExample)
KR (1) KR101807318B1 (enExample)
CN (1) CN102215847B (enExample)
AU (1) AU2009315917B2 (enExample)
BR (1) BRPI0921599B8 (enExample)
CA (1) CA2742449C (enExample)
CY (1) CY1114885T1 (enExample)
DK (1) DK2358374T3 (enExample)
EA (1) EA021707B1 (enExample)
ES (1) ES2437851T3 (enExample)
HR (1) HRP20131084T1 (enExample)
IL (1) IL212442A (enExample)
MX (1) MX2011004744A (enExample)
NZ (1) NZ592528A (enExample)
PL (1) PL2358374T3 (enExample)
PT (1) PT2358374E (enExample)
SI (1) SI2358374T1 (enExample)
SM (1) SMT201400014B (enExample)
WO (1) WO2010054845A1 (enExample)
ZA (1) ZA201103421B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2358374B1 (en) 2008-11-17 2013-09-18 Takeda Nycomed AS Improved dissolution stability of calcium carbonate tablets
EP2575755A2 (en) 2010-06-01 2013-04-10 Cargill, Incorporated Orodispersible tablets of erythritol and isomalt
EP3260114A1 (en) * 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
CN107281216B (zh) * 2017-06-16 2020-05-05 北京济美堂医药研究有限公司 含钙化合物的药物制剂
CN110575440A (zh) * 2018-06-08 2019-12-17 北京新领先医药科技发展有限公司 一种碳酸钙药物组合物的制备方法
HUE068040T2 (hu) 2019-07-05 2024-12-28 Tecnimede Sociedade Tecnico Medicinal Sa Préselt macitentán készítmények, eljárások és ezek felhasználása
JP7774867B2 (ja) * 2021-10-04 2025-11-25 備前化成株式会社 食品錠剤の製造方法
WO2024028300A1 (en) * 2022-08-04 2024-02-08 Symrise Ag Process for the preparation of a powder or of a pastille
KR102675165B1 (ko) * 2023-02-20 2024-06-13 동아제약 주식회사 필름 코팅용 조성물 및 이를 포함하는 필름 코팅액

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115553A (en) * 1973-12-10 1978-09-19 Armour Pharmaceutical Company Antacid tablets
US5204115A (en) 1990-12-12 1993-04-20 Suomen Xyrofin Oy Directly compressible xylitol and method
JP2995226B2 (ja) 1992-03-03 1999-12-27 日本ワイスレダリー株式会社 カルシウム含有チユアブル錠
US5405623A (en) 1993-09-22 1995-04-11 Wm. Wrigley Jr. Company Chewing gum compositions and methods for manufacturing same
DE4427137B4 (de) 1993-10-07 2007-08-23 Degussa Gmbh Fällungskieselsäure
US6716454B2 (en) * 1994-09-23 2004-04-06 Laboratorie Innothera, Société Anonyme Therapeutic combination of vitamin and calcium in unitary galenic tablet form, a method of obtaining it, and the use thereof
FR2724844B1 (fr) 1994-09-23 1997-01-24 Innothera Lab Sa Association therapeutique vitamino-calcique, son procede d'obtention et son utilisation
US5846506A (en) 1994-10-07 1998-12-08 Degussa Aktiengesellschaft Precipitated silicas
DE19617487A1 (de) 1996-05-02 1997-11-06 Merck Patent Gmbh Geschmacksverbesserung von Arzneimittelwirkstoffen
DE69739967D1 (de) 1996-06-14 2010-09-30 Kyowa Hakko Kirin Co Ltd Eine im Mund schnell zerfallende Tablette
FR2762217B1 (fr) 1997-04-16 2000-09-29 Besins Iscovesco Lab Preparation solide vitamino-calcique, son procede d'obtention et son utilisation
ITFI970184A1 (it) 1997-07-30 1999-01-30 Menarini Farma Ind Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
GB9825033D0 (en) 1998-11-13 1999-01-13 Nycomed Pharma As Process
JP2001316249A (ja) 2000-05-11 2001-11-13 Lion Corp 錠剤型医薬組成物
EP1369131A1 (en) 2001-03-06 2003-12-10 Kyowa Hakko Kogyo Co., Ltd. Utilization of spray-dried powder containing sugar alcohol
EP1369109A1 (en) 2001-03-06 2003-12-10 Kyowa Hakko Kogyo Co., Ltd. Preparations quickly disintegrating in oral cavity
IL159584A0 (en) * 2001-07-16 2004-06-01 Astrazeneca Ab Pharmaceutical formulation comprising a proton pump inhibitor and antacids
ES2192136B1 (es) 2002-01-04 2005-03-16 Italfarmaco, S.A. Composiciones farmaceuticas para el tratamiento o prevencion de la osteoporosis.
DE20216314U1 (de) 2002-10-22 2003-12-04 Dhw Deutsche Hydrierwerke Gmbh Rodleben Sprühgetrockneter Xylitol und aus diesem hergestellte Komprimate
MXPA06013608A (es) * 2004-05-24 2007-04-26 Nycomed Pharma As Particulado que comprende un compuesto que contiene calcio y un alcohol de azucar.
JP4996458B2 (ja) 2004-06-01 2012-08-08 ニコメド ファーマ エイエス 活性物質としてカルシウム含有化合物を含み、咀嚼し、舐め、飲み込むことのできる錠剤
JP5224820B2 (ja) * 2005-02-03 2013-07-03 ニコメド ファーマ エイエス カルシウム含有化合物を含む組成物の溶融造粒
UA95093C2 (uk) * 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
AU2006322452B2 (en) * 2005-12-07 2012-07-12 Takeda Nycomed As Pre-compacted calcium-containing compositions
EP2104993A2 (en) 2007-01-16 2009-09-30 Koninklijke Philips Electronics N.V. Device discovery for mixed types of directional terminals
EP2358374B1 (en) 2008-11-17 2013-09-18 Takeda Nycomed AS Improved dissolution stability of calcium carbonate tablets

Also Published As

Publication number Publication date
HRP20131084T1 (hr) 2013-12-20
HK1162354A1 (en) 2012-08-31
AU2009315917B2 (en) 2014-11-20
IL212442A (en) 2015-10-29
BRPI0921599A2 (pt) 2016-02-10
US9101565B2 (en) 2015-08-11
KR101807318B1 (ko) 2018-01-10
IL212442A0 (en) 2011-06-30
JP2012508706A (ja) 2012-04-12
DK2358374T3 (da) 2013-11-11
EP2358374A1 (en) 2011-08-24
PT2358374E (pt) 2013-12-09
CA2742449A1 (en) 2010-05-20
CN102215847B (zh) 2014-07-16
CY1114885T1 (el) 2016-12-14
CA2742449C (en) 2018-04-24
JP5523467B2 (ja) 2014-06-18
SI2358374T1 (sl) 2014-01-31
NZ592528A (en) 2013-05-31
BRPI0921599B1 (pt) 2020-08-18
CN102215847A (zh) 2011-10-12
SMT201400014B (it) 2014-03-07
KR20110086592A (ko) 2011-07-28
US20110287098A1 (en) 2011-11-24
EA201170695A1 (ru) 2011-12-30
US20160022732A1 (en) 2016-01-28
PL2358374T3 (pl) 2014-03-31
AU2009315917A1 (en) 2010-05-20
EA021707B1 (ru) 2015-08-31
EP2358374B1 (en) 2013-09-18
ES2437851T3 (es) 2014-01-14
MX2011004744A (es) 2011-05-30
WO2010054845A1 (en) 2010-05-20
US9999634B2 (en) 2018-06-19
BRPI0921599B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
ZA201103421B (en) Improved dissolution stability of calcium carbonate tablets
EP2519483A4 (en) METHOD AND COMPOSITIONS WITH CALCIUM CARBONATE
ZA201203170B (en) Production of calcium carbonate
EP2251005A4 (en) TABLETS OFFERING ORALLY
EP2116576A4 (en) POLYLACTIC ACID COMPOSITION
GB0801416D0 (en) Pharmaceutical compounds
SI2442799T2 (sl) Trden farmacevtski sestavek, ki obsega rivaroksaban
IL220014A0 (en) Microcrystalline cellulose and calcium carbonate compositions useful as recompactible pharmaceutical excipients
PL2385766T3 (pl) Kompozycja zawierająca węglan wapnia jako biały pigment
GB0812969D0 (en) Pharmaceutical compounds
GB0816370D0 (en) Pharmaceutical compounds
GB0806527D0 (en) Pharmaceutical compounds
PL2273994T3 (pl) Postacie w stanie stałym leku
IL210102A0 (en) Pharmaceutical compositions of rosuvastatin calcium
GB0810857D0 (en) Pharmaceutical compounds
GB0703761D0 (en) Polylactic acid stereocomplex
FR2928356B1 (fr) Distributeur de comprimes
GB0715626D0 (en) Crystalline form of zofenopril calcium
ZA201100163B (en) Unit dosage of apadenoson
ZA201104564B (en) Low dosage controlled release tablet
GB0900746D0 (en) Delay-line self oscillator
IL211688A (en) Crystalline form ii of calcium 3-acetylaminopropane-1-sulfonate
GB2460445B (en) Treatment of ringworm
GB0807502D0 (en) Pharmaceutical compounds
GB0802252D0 (en) Pharmaceutical compounds